About 2017-08-28T05:10:05+00:00


Sayre Therapeutics was
founded in 2015 backed by leading
global Venture Capital (VC) firms.

The team boasts 25 years of global executive experience in leading Pharmaceutical, Medical Diagnostics & Devices companies. Sayre Therapeutics has been identified as a high potential healthcare company with a pedigree team with proven wins and a robust clinician network in the Oncology / Immunology space. The company is uniquely positioned with a first-mover advantage, which allows for it to quickly create a portfolio of differentiated global assets in emerging markets.

Our geographic footprint covers India, South East Asia and SAARC countries which are witnessing a high growth rate across the disease areas of interest.

Sayre Therapeutics with its focused strategy, strong financial backing and established relationships with clinicians and regulatory know-how, will be nimble, allowing for faster acquisitions of assets and revenue ramp ups in identified markets. To that end, Sayre will prove to be a committed partner to licensors for their global assets.


We will become Asia’s specialized healthcare company of choice, providing patients and clinicians access to high-quality novel medical solutions for life-threatening diseases.


We facilitate access to differentiated medical solutions to patients and clinicians in emerging markets by identifying high unmet needs across the healthcare continuum. We engage with global partners and customers, enabling commercial innovations through strategy and superior science, to drive profitable growth.


Shukrit Sudhir Chimote

Chief Executive Officer

Shukrit has had a proven track record in the Pharmaceutical Industry and prior to co-founding Sayre Therapeutics, he served as Vice-President and India & South Asia Head, Branded Formulations at a premier Indian biotech. His responsibilities spanned the breadth of commercial operations (sales, marketing, medical, HR, Learning & Development, distribution, sourcing, formulations development, inventory management and regulatory teams).


Vandana Subramanian

Chief Business Officer

At Sayre Therapeutics, Vandana leads global in-licensing activities, product portfolio, alliance management and corporate strategy. At a leading Indian biotech, Vandana was the Associate Director, Business development, setting up a new vertical in molecular diagnostics and drug delivery devices across multiple therapeutic areas.


Praveen Bose

Senior Vice President and Head of Sales & Marketing

In his current role, Praveen spearheads sales, marketing and commercial operations for all products and services that are being commercialized in India. He manages a team of seasoned professionals across these functions. Praveen was associated with leading organizations like Pharmacia & Upjohn, Biocon, Dabur Oncology and Ferring in various leadership roles, predominantly in Oncology and Immunology super specialties.


Dr Ravindranath Kunjithai

Associate Vice President and Head of Medical & Regulatory Affairs

He leads a team that is responsible for providing scientific communication regarding the products, lead/conduct clinical trials, provide medical information/education, and guide products through the regulatory pathway. Prior to his role in Sayre Therapeutics Ravi held a leadership role in Novartis Healthcare in its Global Medical Operations in India.